Successful use of letrozole in male breast cancer: A case report and review of hormonal therapy for male breast cancer

被引:45
|
作者
Zabolotny, BP [1 ]
Zalai, CV [1 ]
Meterissian, SH [1 ]
机构
[1] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Surg Oncol, Montreal, PQ H3A 1A1, Canada
关键词
male breast neoplasms; aromatase inhibitors;
D O I
10.1002/jso.20233
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Male breast cancer is an uncommon occurrence. Treatment of male breast cancer is typically extrapolated from data on the treatment of female breast cancer. Recently, aromatase inhibition has been proven as an effective therapy for female breast cancer, particularly in the setting of advanced cancers. The efficacy of aromatase inhibitors in males, however, has not been established. We report the successful treatment of a male with locally advanced breast cancer using the aromatase inhibitor letrozole. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:26 / 30
页数:5
相关论文
共 50 条
  • [41] Sequencing of hormonal therapy in postmenopausal women with metastatic breast cancer
    Parker, LM
    CLINICAL THERAPEUTICS, 2002, 24 : C43 - C57
  • [42] Letrozole as Primary Medical Therapy for Locally Advanced and Large Operable Breast Cancer
    J.M. Dixon
    C.D.B. Love
    C.O.C. Bellamy
    D.A. Cameron
    R.C.F. Leonard
    H. Smith
    W.R. Miller
    Breast Cancer Research and Treatment, 2001, 66 : 191 - 199
  • [43] Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
    Murphy, Caitlin C.
    Bartholomew, L. Kay
    Carpentier, Melissa Y.
    Bluethmann, Shirley M.
    Vernon, Sally W.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 459 - 478
  • [44] Letrozole as primary medical therapy for locally advanced and large operable breast cancer
    Dixon, JM
    Love, CDB
    Bellamy, COC
    Cameron, DA
    Leonard, RCF
    Smith, H
    Miller, WR
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 66 (03) : 191 - 199
  • [45] Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials
    Abrial, Catherine
    Durando, Xavier
    Mouret-Reynier, Marie-Ange
    Thivat, Emilie
    Bayet-Robert, Mathilde
    Nayl, Beatrice
    Dubray, Pascale
    Pomel, Christophe
    Chollet, Philippe
    Penault-Llorca, F.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2009, 2 : 129 - 140
  • [46] Neoadjuvant use of endocrine therapy in breast cancer
    Macaskill, E. Jane
    Dixon, J. Michael
    BREAST JOURNAL, 2007, 13 (03) : 243 - 250
  • [47] A Single Institution Consensus on the Use of Sequential or Concurrent Hormonal Therapy for Breast Cancer Patients Receiving Radiation Therapy
    Cecchini, Matthew J.
    Yu, Edward
    Yaremko, Brian P.
    Boldt, R. Gabriel
    Potvin, Kylea
    Sexton, Tracy
    D'Souza, David
    Brackstone, Muriel
    Lock, Michael
    CUREUS, 2016, 8 (04):
  • [48] Hormonal Modulation in the Treatment of Breast Cancer
    Adelson, Kerin
    Germain, Doris
    Raptis, George
    Biran, Noa
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2011, 40 (03) : 519 - +
  • [49] Examining factors associated with adherence to hormonal therapy in breast cancer patients
    Shah, Chintal H.
    Balkrishnan, Rajesh
    Diaby, Vakaramoko
    Xiao, Hong
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (04) : 574 - 582
  • [50] Cognitive Deficits in Breast Cancer Survivors After Chemotherapy and Hormonal Therapy
    Frank, Jennifer Sandson
    Vance, David E.
    Triebel, Kristen L.
    Meneses, Karen M.
    JOURNAL OF NEUROSCIENCE NURSING, 2015, 47 (06) : 302 - 312